WallStreetZenWallStreetZen

NYSE: ANRO
Alto Neuroscience Inc Earnings & Revenue

ANRO earnings and revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

ANRO Return on Equity

Insufficient data to display

Be the first to know when ANRO announces earnings.

ANRO Return on Assets

Insufficient data to display

ANRO Return on Capital Employed

Current Company
0%
Current Industry
-42.5%

ANRO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ANRON/AN/AN/AN/AN/A
IMMP$4.40MN/A-$26.47M+4.12%N/A
AVIR$0.00-$162.19M-$163.66M-100.00%N/A
STTK$2.72M-$80.70M-$85.08M-89.03%N/A
NAUT$0.00-$61.32M-$67.44MN/AN/A

Alto Neuroscience Earnings & Revenue FAQ

What were ANRO's earnings last quarter?

Alto Neuroscience (NYSE: ANRO) reported Q1 2024 earnings per share (EPS) of -$0.76, up 61.42% year over year. Total Alto Neuroscience earnings for the quarter were -$13.42 million. In the same quarter last year, Alto Neuroscience's earnings per share (EPS) was -$1.97.

If you're new to stock investing, here's how to buy Alto Neuroscience stock.

What was ANRO's earnings growth in the past year?

As of Q2 2024, Alto Neuroscience's earnings has grown year over year. Alto Neuroscience's earnings in the past year totalled N/A.

What was ANRO's revenue last quarter?

Alto Neuroscience (NYSE: ANRO) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Alto Neuroscience's revenue was $0.00.

What was ANRO's revenue growth in the past year?

As of Q2 2024, Alto Neuroscience's revenue has grown null year over year. Alto Neuroscience's revenue in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.